Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclic Hypoxia: An Update on Its Characteristics, Methods to Measure It and Biological Implications in Cancer
Samuel B. Bader, Mark W. Dewhirst, Ester M. Hammond
Cancers (2020) Vol. 13, Iss. 1, pp. 23-23
Open Access | Times Cited: 105

Showing 1-25 of 105 citing articles:

The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies
Ruixue Bai, Yunong Li, Lingyan Jian, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 160
Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter
Tord Hompland, Christina S. Fjeldbo, Heidi Lyng
Cancers (2021) Vol. 13, Iss. 3, pp. 499-499
Open Access | Times Cited: 132
Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing
Alexander E. Kabakov, A. O. Yakimova
Cancers (2021) Vol. 13, Iss. 5, pp. 1102-1102
Open Access | Times Cited: 106
Lactate Dehydrogenase and its clinical significance in pancreatic and thoracic cancers
Annalisa Comandatore, Marika Frańczak, Ryszard T. Smoleński, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 93-100
Open Access | Times Cited: 72
The Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
Martyna Jaworska, Julia Szczudło, Adrian Pietrzyk, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 4, pp. 876-890
Open Access | Times Cited: 58
Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies
Anchal Pathak, Ajay Kumar Pal, Subhadeep Roy, et al.
Stem Cells International (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 16
Research progress on tumor hypoxia-associative nanomedicine
Xiaoxue Xu, Siyi Chen, Ningbo Yi, et al.
Journal of Controlled Release (2022) Vol. 350, pp. 829-840
Closed Access | Times Cited: 54
Targeting HIF-2α in the Tumor Microenvironment: Redefining the Role of HIF-2α for Solid Cancer Therapy
Leah Davis, Matthias Recktenwald, Evan Hutt, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1259-1259
Open Access | Times Cited: 52
Biological Mechanisms to Reduce Radioresistance and Increase the Efficacy of Radiotherapy: State of the Art
F. Busato, Badr El Khouzai, Maddalena Mognato
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10211-10211
Open Access | Times Cited: 34
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statements on pre-invasive vulvar lesions
Mario Preti, Elmar A. Joura, Pedro Vieira‐Baptista, et al.
International Journal of Gynecological Cancer (2022) Vol. 32, Iss. 7, pp. 830-845
Open Access | Times Cited: 30
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Joanna Ciepła, Ryszard Smolarczyk
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 8
Spatiotemporal oxygen dynamics in young leaves reveal cyclic hypoxia in plants
Paolo M. Triozzi, Luca Brunello, Giacomo Novi, et al.
Molecular Plant (2024) Vol. 17, Iss. 3, pp. 377-394
Open Access | Times Cited: 7
Revisiting reactive oxygen species production in hypoxia
Ricardo Alva, Jacob E. Wiebe, Jeffrey A. Stuart
Pflügers Archiv - European Journal of Physiology (2024) Vol. 476, Iss. 9, pp. 1423-1444
Closed Access | Times Cited: 7
Epigenetic modulation of neuroblastoma enhances T cell and NK cell immunogenicity by inducing a tumor-cell lineage switch
Annelisa M. Cornel, Ester Dünnebach, Damon A. Hofman, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 12, pp. e005002-e005002
Open Access | Times Cited: 26
Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer
Iris C. Salaroglio, Dimas Carolina Belisario, Muhlis Akman, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 24
The Role of the Hypoxia-Related Unfolded Protein Response (UPR) in the Tumor Microenvironment
Sylwia Bartoszewska, James F. Collawn, Rafał Bartoszewski
Cancers (2022) Vol. 14, Iss. 19, pp. 4870-4870
Open Access | Times Cited: 24
Targeting the redox imbalance in mitochondria: A novel mode for cancer therapy
Shalini Mani, Geeta Swargiary, Stephen J. Ralph
Mitochondrion (2021) Vol. 62, pp. 50-73
Closed Access | Times Cited: 31
DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies
Ola Rominiyi, Spencer J. Collis
Molecular Oncology (2021) Vol. 16, Iss. 1, pp. 11-41
Open Access | Times Cited: 29
Cellular mechanism of action of 2-nitroimidazoles as hypoxia-selective therapeutic agents
Faisal Bin Rashed, Diana Diaz‐Dussan, Fatemeh Mashayekhi, et al.
Redox Biology (2022) Vol. 52, pp. 102300-102300
Open Access | Times Cited: 22
Acute vs. chronic vs. intermittent hypoxia in breast Cancer: a review on its application in in vitro research
Qiuyu Liu, Victoria A. C. Palmgren, Erik H.J. Danen, et al.
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10961-10973
Open Access | Times Cited: 22
Accurate Three-Dimensional Thermal Dosimetry and Assessment of Physiologic Response Are Essential for Optimizing Thermoradiotherapy
Mark W. Dewhirst, James R. Oleson, John P. Kirkpatrick, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1701-1701
Open Access | Times Cited: 21
The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia
Bernard Gallez
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 21
Monitoring mitochondrial nitroreductase activity in tumors and a hind-limb model of ischemia in mice using a novel activatable NIR fluorescent probe
Xiaosheng Liu, Shuang Zeng, Ming Zhang, et al.
Chemical Communications (2022) Vol. 58, Iss. 81, pp. 11438-11441
Closed Access | Times Cited: 20
Growth and adaptation mechanisms of tumour spheroids with time-dependent oxygen availability
Ryan J. Murphy, Gency Gunasingh, Nikolas K. Haass, et al.
PLoS Computational Biology (2023) Vol. 19, Iss. 1, pp. e1010833-e1010833
Open Access | Times Cited: 12
“Pulsed Hypoxia” Gradually Reprograms Breast Cancer Fibroblasts into Pro-Tumorigenic Cells via Mesenchymal–Epithelial Transition
Anna A. Nushtaeva, Mikhail Ermakov, M.M. Abdurakhmanova, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2494-2494
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top